Phase CEO Albert Burla spoke with the Financial Times today (Saturday) about the decision to make Israel the first significant customer of the company's corona vaccines and praised former Prime Minister Benjamin Netanyahu for his conduct.
Burla told a reporter, David Crowe, during lunch at a Greek restaurant in New York that he had heard that "in Tel Aviv, glasses are being raised for Pfizer's life." The article states that Israel received vaccines made by Pfizer for its entire population, in exchange for medical data that will show how effective the vaccine is.
Bula told the reporter that what made him choose Israel is its relatively small population size with an impressive electronic data collection capability. Burla said it was easy to choose Greece, but the country's medical data collection system did not meet the conditions set by the company. Burla said Sweden was also being considered, but the CEO feared it would upset other European countries.
The former prime minister alongside Pfizer vaccines who arrived in Israel, Moti Milrod, GPO
"The thing that became clear very quickly was the level of proficiency and control of Bibi Netanyahu, he just knew everything. He would call me every half hour and ask, 'What about the young people?' How do they respond to the vaccine? What about the South African variant? What are you doing about it? ' I'm sure he did all this for his people, but I'm sure he thought "it could very well serve me politically," said Burla reporter.
When reading an article at the end and that Netanyahu was forced to give up power, the CEO replied: "Maybe, But he performed well. "
Burla also spoke about the conversation he had at the time with the Python department of the Biotech company, in which the data indicated the efficacy of more than 95 of the vaccine developed. "I thought I did not hear well from Ahmanitif," the CEO admitted.We will be in a very problematic place. "